This company has been marked as potentially delisted and may not be actively trading. Dova Pharmaceuticals (DOVA) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock DOVA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Lifelines AheadJuly 19, 2024 | bizjournals.comCumberland Valley School Board reinstates assembly featuring ’30 Rock’ star after special meetingApril 25, 2024 | msn.comAnalysis of Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology Signed During 2016-2024March 7, 2024 | uk.finance.yahoo.comFulcrum swings back up after FDA lifts clinical holdAugust 22, 2023 | bizjournals.comFulcrum Therapeutics Appoints Alex C. Sapir Chief Executive OfficerMay 15, 2023 | technews.tmcnet.comImmune Thrombocytopenia Market 2023 Size to reach USD 3.33 Billion by 2026 With A 0.54% CAGRMarch 29, 2023 | marketwatch.comWith A 0.54% CAGR, Immune Thrombocytopenia Market 2023 Size Will Reach USD 3.33 Billion by 2026March 21, 2023 | marketwatch.comLatest Research on Chemotherapy Induced Thrombocytopenia Drugs Market Report 2023-2029February 27, 2023 | marketwatch.comGlobal Immune Thrombocytopenia Treatment Market Size To Grow On The Basis Of Refined Innovation From 2023-2030 By VMReportsFebruary 19, 2023 | marketwatch.comPasithea Therapeutics Appoints Life Sciences and Health Care Executive Alfred J. Novak to its Board of DirectorsSeptember 20, 2022 | finance.yahoo.comTethys Oil AB (TETY)September 14, 2022 | investing.comMolina Healthcare (NYSE: MOH)August 11, 2022 | fool.comUK watchdog fines Pfizer, Flynn Pharma $84 million for overcharging NHSJuly 23, 2022 | uk.news.yahoo.comGlobal Immune Thrombocytopenia Market to Rise at 0.54% CAGR from 2019-2026July 19, 2022 | marketwatch.comDOVA_old Historical DataJune 9, 2022 | investing.com'This is not pressure' - Passionate Parker issues rallying cry ahead of huge Blackburn clashApril 30, 2022 | uk.finance.yahoo.comUkraine Holocaust survivors find shelter in IsraelApril 30, 2022 | reuters.comImmune Thrombocytopenia (ITP) Market Research Update, Size Estimation, Future Scope, Revenue Opportunities and Regional Forecast to 2028March 24, 2022 | marketwatch.comVerona Pharma Reports Third Quarter 2021 Financial Results and Provides Corporate UpdateNovember 9, 2021 | benzinga.comAdvent, GIC Affiliate Launch $8.1 Bln Takeover Bid for Sweden's SobiSeptember 2, 2021 | marketwatch.com Get Dova Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for DOVA and its competitors with MarketBeat's FREE daily newsletter. Email Address DOVA Media Mentions By Week DOVA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DOVA News Sentiment▼0.000.65▲Average Medical News Sentiment DOVA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DOVA Articles This Week▼00▲DOVA Articles Average Week Get Dova Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for DOVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MOR News Today CALT News Today ZYME News Today CMRX News Today CDMO News Today RVNC News Today CKPT News Today MBX News Today TSVT News Today SLRN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DOVA) was last updated on 6/23/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dova Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Dova Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DOVA Stock Free DOVA Stock Alerts